Kybella®

Look Younger with A New, Non-invasive FDA-Approved Treatment

Submental fullness, better known as “double chin”, can make you look older or heavier. Today, there is a new treatment -- Kybella™ -- that improves the appearance of moderate to severe fullness associated with submental fat in adults.

As the first and only approved new injectable drug by the U.S. Food and Drug Administration (FDA) for the reduction of submental fat, Kybella can significantly improve chin contouring without the invasiveness and downtime of surgical options. It’s a substance naturally synthesized by our body and used to break down and absorb dietary fat.

A Natural Occurring Substance That Breaks Down Fat

Kybella is a synthetic formulation of deoxycholic acid, a naturally-occurring molecule in the body that aids in the breakdown and absorption of dietary fat. Kybella has been under development for more than 9 years, and has been the subject of over 20 clinical studies involving more than 2600 patients.

When injected into subcutaneous fat, Kybella has been shown to dissolve submental fat (which causes double chin). Once destroyed, those cells cannot store or accumulate fat. The results are a more youthful appearance from a significant cosmetic improvement due to a more streamline contour along the jawline.

Non-invasive & Only Typically 20 Minutes to Administer

Kybella is administered by injections into the fat under the chin through a series of treatments with each in-office treatment typically taking only 15-20 minutes. Your treatments are customized to meet your aesthetic goals for an improved chin profile. The total number of treatments varies – typically in the range between 2 and 5.

Great Results In A Short Time

After your treatment, results typically appear within weeks to months, and keep improving as additional treatments are administered. Many patients experience visible results in two to four treatments and Kybella has a high patient satisfaction based on clinical studies. Patients also reported being happier and less self-conscious following their treatments.

Kybella’s FDA approval was based on two clinical trials involving more than a thousand patients with moderate to severe submental fat, who received injections of either Kybella or a placebo. Patients that received Kybella saw a noticeable and cosmetically significant reduction of submental fat compared to patients that received the placebo.

Safe & Reliable, Quality-Assured Treatment

Kybella is a highly controlled, quality-assured and validated treatment, and its current Good Manufacturing Practices-compliant process ensures patient safety. It contains no human or animal-derived substances.

Side effects were comparable to other cosmetic injections and may include swelling, bruising, pain, numbness, redness or formation of small areas of firmness. In very rare cases, injection in outside fat deposits could damage skin tissue. Most side effects resolved on their own within 1-2 months of treatment.